Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: NIH

NIH unable to comply with FOIA on its ivermectin recommendation

The NIH updated its recommendation on the use of ivermectin in COVID-19 on January 14. The updated recommendation stated: “There are insufficient […]

NIH unable to comply with FOIA on its ivermectin recommendation
20 hours ago
Share

Monoclonal Antibodies Against MERS Coronavirus Show Promise in Phase 1 NIH-sponsored Trial

A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East […]

Monoclonal Antibodies Against MERS Coronavirus Show Promise in Phase 1 NIH-sponsored Trial
6 days ago
Share

U.S. Dept HHS: An Important Physicians Organization Suggests More Transparency in Research

Recently, a committed non-profit organization known as Doctors Without Borders/Médecins Sans Frontières (MSF) issued a call for more transparency in clinical research. […]

U.S. Dept HHS An Important Physicians Organization Suggests More Transparency in Research
1 week ago
Share

News Roundup | Egypt Ivermectin-based Study Results Are In

Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: […]

1 week ago
Share

NIH Funds Phase 1 Safety Study Comparing Use of Remdesivir in Pregnant Women Hospitalized with COVID-19 to Women Not Pregnant

The National Institutes of Health (NIH) along with their National Institutes of Child Health and Human Development (NICHD) and the […]

NIH Funds Phase 1 Safety Study Comparing Use of Remdesivir in Pregnant Women Hospitalized with COVID-19 to Women Not Pregnant
2 weeks ago
Share

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial

Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe […]

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial
2 weeks ago
Share

Beyond The Roundup | Bill and Melinda Gates Fund Global Ivermectin Clinical Trial

Bill and Melinda Gates Fund Global Ivermectin & Fluvoxamine Clinical Trial Targeting COVID-19: Together COVID-19 Trial:A Principal Investigator from McMaster […]

3 weeks ago
Share

NIH COVID-19 Treatment Guidelines Panel Updates Position on Ivermectin

The National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel just updated their guidelines on ivermectin for COVID-19. Essentially the same […]

WHO Looking at Ivermectin within Weeks as COVID-19 for Early Onset Treatment
3 weeks ago
Share

News Roundup | Merck Challenges Safety & Validity Of Ivermectin Studies

Merck Challenges Safety & Validity of All Ivermectin Studies for COVID-19, Despite Having Donated Billions of Doses to Less-Developed World […]

3 weeks ago
Share

Beyond The Roundup | Another NY Judge Orders A Hospital To Use Ivermectin

For the Second Time New York Doctors and Patients Needed to Go to Court to Access Ivermectin. The first incident, […]

4 weeks ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.